Literature DB >> 19686788

Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine.

Shailja Tiwari1, Amit K Goyal, Neeraj Mishra, Kapil Khatri, Bhuvaneshwar Vaidya, Abhinav Mehta, Yimin Wu, Suresh P Vyas.   

Abstract

The aim of present work was to investigate the potential utility of novel carrier gel core liposomes for intramuscular delivery of transmission blocking malaria antigen Pfs25 and to evaluate the effect of co-administration of vaccine adjuvant CpGODN on immune enhancement of recombinant protein antigen Pfs25. In the present work we have prepared gel core liposomes containing core of biocompatible polymer poly acrylic acid in phospholipid bilayer by reverse phase evaporation method and characterized for various in vitro parameters. In process stability of the encapsulated antigen was evaluated by SDS-PAGE followed by western blotting. The immune stimulating ability was studied by measuring anti-Pfs25 antibody titer in serum of Balb/c mice following intramuscular administration of various formulations. A Significant and perdurable immune responses was obtained after intramuscular administration of gel core liposomes encapsulated Pfs25 as compared to Pfs25 loaded conventional liposomes. Moreover co-administration of CpGODN in liposomes (conventional and gel core) was found to further increase the immunogenicity of vaccine. The result indicates high potential of gel core liposomes for their use as a carrier adjuvant for intramuscular delivery of recombinant antigen Pfs25 based transmission blocking malaria vaccine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19686788     DOI: 10.1016/j.jconrel.2009.08.004

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  10 in total

1.  Novel Self-assembled, Gel-core Hyaluosomes for Non-invasive Management of Osteoarthritis: In-vitro Optimization, Ex-vivo and In-vivo Permeation.

Authors:  Wessam M El-Refaie; Yosra S R Elnaggar; Magda A El-Massik; Ossama Y Abdallah
Journal:  Pharm Res       Date:  2015-03-17       Impact factor: 4.200

2.  Preparation, characterization, and evaluation of eosin B-loaded nano-liposomes for growth inhibition of Plasmodium falciparum.

Authors:  Mana Najafzadeh; Haleh Bakhshandeh; Zahra Zamani; Monire Movahedi; Seyed Mohammad Atyabi
Journal:  Parasitol Res       Date:  2022-01-06       Impact factor: 2.289

3.  Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells.

Authors:  Cheng-Wei Chen; Da-Wen Lu; Ming-Kung Yeh; Chia-Yang Shiau; Chiao-Hsi Chiang
Journal:  Int J Nanomedicine       Date:  2011-10-26

4.  Efficient downregulation of VEGF in retinal pigment epithelial cells by integrin ligand-labeled liposome-mediated siRNA delivery.

Authors:  Cheng-Wei Chen; Ming-Kung Yeh; Chia-Yang Shiau; Chiao-Hsi Chiang; Da-Wen Lu
Journal:  Int J Nanomedicine       Date:  2013-07-22

Review 5.  Strategies & recent development of transmission-blocking vaccines against Plasmodium falciparum.

Authors:  Neha Chaturvedi; Praveen K Bharti; Archana Tiwari; Neeru Singh
Journal:  Indian J Med Res       Date:  2016-06       Impact factor: 2.375

Review 6.  Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines.

Authors:  Aloysious Ssemaganda; Ashwini Kumar Giddam; Mehfuz Zaman; Mariusz Skwarczynski; Istvan Toth; Danielle I Stanisic; Michael F Good
Journal:  Front Immunol       Date:  2019-02-01       Impact factor: 7.561

Review 7.  Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria.

Authors:  Lohitha Gujjari; Hamed Kalani; Sai Kiran Pindiprolu; Bhanu Prakash Arakareddy; Ganesh Yadagiri
Journal:  Parasite Epidemiol Control       Date:  2022-02-16

8.  Single-dose microparticle delivery of a malaria transmission-blocking vaccine elicits a long-lasting functional antibody response.

Authors:  R R Dinglasan; J S Armistead; J F Nyland; X Jiang; H Q Mao
Journal:  Curr Mol Med       Date:  2013-05       Impact factor: 2.222

Review 9.  The Use of Synthetic Carriers in Malaria Vaccine Design.

Authors:  Liam Powles; Sue D Xiang; Cordelia Selomulya; Magdalena Plebanski
Journal:  Vaccines (Basel)       Date:  2015-10-29

Review 10.  Liposomes for malaria management: the evolution from 1980 to 2020.

Authors:  Patrick B Memvanga; Christian I Nkanga
Journal:  Malar J       Date:  2021-07-27       Impact factor: 2.979

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.